- Chronic Diseases / Disorders
- Community Health Centres
- Fetal Alcohol Spectrum Disorder (FASD)
- Health Economics / Healthcare Costs
- Health Measurement Tools
- Health Policy
- Health Technology Assessment
- Healthcare Services
- Infectious Diseases
- Maternal and Child Health
- Mental Health
- Nurse Practitioners
- Primary Care
- Quality of Life
Criteria for the Clinical Use of Immune Globulin, 1st Edition – Background Document - April 2018
This background document outlines the methods used to develop the Criteria for the Clinical Use of Immune Globulin, which was produced as part of the Prairie Collaborative Immune Globulin Utilization Management Framework project.
The Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project was initiated to establish criteria for IG therapy as a means to increase accountability for the quality, safety, and sustainability of the blood supply system, and to demonstrate stewardship for the use of public funds. This project is a trilateral agreement between the Alberta, Manitoba, and Saskatchewan ministries of health, involved multidisciplinary committees comprised of specialists from the three provinces, and was supported by a research team from the Ambassador Guideline Adaptation and Development Program at the Institute of Health Economics (IHE).
Prairie Collaborative Immune Globulin Utilization Management Framework Project. Criteria for the clinical use of immune globulin, 1st edition: Background document. Alberta Ministry of Health, Shared Health Manitoba, and Saskatchewan Ministry of Health; 2018.
Year of Publication: 2018
Authors: Prairie Collaborative Immune Globulin Utilization Management Framework Project